Imatinib and anaemia Patient Reports February 11, 2012

Imatinib Side Effects Report #5699648-6
Imatinib side effect was reported by a Physician from UNITED STATES on Mar 28, 2008. Female patient, 73 years of age, weighting 178.6 lb, was diagnosed with malignant melanoma, atrial fibrillation  and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, atrial flutter, dyspnoea. Imatinib dosage: 600MG DAILY. During the same period patient was treated with TEMOZOLOMIDE, TOPROL, RYTHMOL. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5699679-6
Imatinib side effect was reported by a Physician from UNITED STATES on Mar 31, 2008. Female patient, 73 years of age, weighting 178.6 lb, was diagnosed with malignant melanoma, atrial fibrillation  and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, atrial flutter, dyspnoea. Imatinib dosage: 600MG DAILY. During the same period patient was treated with TEMOZOLOMIDE, TOPROL, RYTHMOL, LOVENOX. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #4707004-X
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 05, 2005. Female patient, 63 years of age, weighting 122.6 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Imatinib dosage: 400 MG, PO QD. During the same period patient was treated with HYDROXYUREA, ACTONEL, DIOVAN, NORVASC, HYDROXYCHLOROQUINE SULPHATE, LEVOXYL. Patient recovered.

Imatinib Side Effects Report #4763753-9
Imatinib side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 31, 2005. Female patient, 60 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, haemodynamic instability, haemoglobin decreased, ileus paralytic, intra-abdominal haemorrhage, liver function test abnormal, malignant neoplasm progression. Imatinib dosage: 400 MG, BID. Patient was hospitalized. Patient died.


Imatinib Side Effects Report #5875914-6
Imatinib side effect was reported by a Consumer or non-health professional from GREECE on Sept 03, 2008. Male patient, 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, blast crisis in myelogenous leukaemia, blood product transfusion dependent, cytogenetic abnormality, gastrointestinal haemorrhage, multiple myeloma , plasmacytosis. Imatinib dosage: 400 MG, QD. During the same period patient was treated with INTERFERON ALFA. Patient died.

Imatinib Side Effects Report #6070047-0
Imatinib side effect was reported by a Health Professional from GREECE on Feb 03, 2009. Male patient, 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, blast crisis in myelogenous leukaemia, blood product transfusion dependent, cytogenetic abnormality, gastrointestinal haemorrhage, multiple myeloma , plasmacytosis. Imatinib dosage: 400 MG, QD. During the same period patient was treated with INTERFERON ALFA. Patient died.

Imatinib Side Effects Report #5064511-0
Imatinib side effect was reported by a Health Professional from CZECH REPUBLIC on July 18, 2006. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, chronic lymphocytic leukaemia, coronary artery disease . Imatinib dosage: 400 MG/D. Patient recovered.

Imatinib Side Effects Report #5949376-4
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 07, 2008. Female patient, 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blast crisis in myelogenous leukaemia, blood creatinine increased, blood urea increased, ejection fraction abnormal, enterococcal bacteraemia, haemorrhage, hypoxia. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient died.

Imatinib Side Effects Report #6060818-9
Imatinib side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2009. Female patient, 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blast crisis in myelogenous leukaemia, blood creatinine increased, blood urea increased, ejection fraction abnormal, enterococcal bacteraemia, haemorrhage, hypoxia. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient died.


Imatinib Side Effects Report #5430651-7
Imatinib side effect was reported by a Consumer or non-health professional from SPAIN on Aug 08, 2007. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, INTERFERON ALFA. Patient recovered.

Imatinib Side Effects Report #4883596-5
Imatinib side effect was reported by a Physician from SPAIN on Jan 06, 2006. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #5718064-1
Imatinib side effect was reported by a Health Professional from FRANCE on Apr 11, 2008. Male patient, 54 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, bone pain, chloroma, thrombocytopenia. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #5864045-7
Imatinib side effect was reported by a Health Professional from PAKISTAN on June 05, 2008. Male patient, 51 years of age, was diagnosed with chronic myeloid leukaemia, arthralgia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, anaemia, arthralgia, ascites, blood bilirubin increased, bone marrow failure, dizziness , dyspnoea. Imatinib dosage: 400MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, DICLOFENAC, TRANSFUSIONS. Patient died.

Imatinib Side Effects Report #5477895-6
Imatinib side effect was reported by a Health Professional from CANADA on Sept 28, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, cytogenetic abnormality, myelodysplastic syndrome, perianal abscess. Imatinib dosage: 400 MG/D. During the same period patient was treated with HYDROXYUREA. Patient recovered.


Imatinib Side Effects Report #5578795-3
Imatinib side effect was reported by a Pharmacist from UNITED STATES on Dec 28, 2007. Male patient, 61 years of age, was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, haemorrhage, pancytopenia. Imatinib dosage: 200MG HS PO. Patient recovered.

Imatinib Side Effects Report #5999916-4
Imatinib side effect was reported by a Health Professional from SPAIN on Dec 04, 2008. Female patient, 46 years of age, was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, electrocardiogram qrs complex abnormal, intracardiac mass, intracardiac thrombus, left ventricular dysfunction, pancreatic enzymes increased, surgery , thrombocytopenia. Imatinib dosage: 200 MG/DAY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.